In the present study, we demonstrate that fluorescent anti-IGF-1R antibodies target pancreatic cancer in orthotopic mouse models enabling non-invasive imaging and high resolution intra-vital imaging of the tumor. This evidence concerns the gene IGF1R and pancreatic neoplasm.